Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
215.5 USD | +1.72% | -1.32% | +4.74% |
15/04 | Morgan Stanley Adjusts Primerica's Price Target to $250 From $245, Keeps Equalweight Rating | MT |
19/03 | Primerica Insider Sold Shares Worth $365,115, According to a Recent SEC Filing | MT |
Strengths
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company appears highly valued given the size of its balance sheet.
- The company is not the most generous with respect to shareholders' compensation.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+4.74% | 7.35B | B | ||
+2.96% | 98.12B | B- | ||
+2.63% | 95.14B | B | ||
-15.06% | 82.75B | B+ | ||
+17.51% | 74.13B | D+ | ||
+8.49% | 30.53B | B | ||
+19.06% | 28.31B | B | ||
+6.64% | 27.58B | A | ||
+0.28% | 17.24B | C+ | ||
-9.75% | 15.04B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- PRI Stock
- Ratings Primerica, Inc.